Work

Erlotinib (Tarceva): An update on the clinical trial program

Year: 2003

Type: article

Source: Seminars in Oncology

DOI: 10.1016/s0093-7754(03)00184-2

Author: Roy S. Herbst

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2156394877

FWCI: 5.352

Cites: 48

Cited by: 97

Related to: 10